Combining curcumin (diferuloylmethane) and heat shock protein inhibition for neurofibromatosis 2 treatment: analysis of response and resistance pathways. (Record no. 21143808)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01964 a2200517 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516054039.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201203s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1538-8514 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1158/1535-7163.MCT-11-0243 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Angelo, Laura S |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20120315 |
245 00 - TITLE STATEMENT | |
Title | Combining curcumin (diferuloylmethane) and heat shock protein inhibition for neurofibromatosis 2 treatment: analysis of response and resistance pathways. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Molecular cancer therapeutics |
Date of publication, distribution, etc. | Nov 2011 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 2094-103 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Apoptosis |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Benzhydryl Compounds |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line, Tumor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Proliferation |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Curcumin |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Resistance, Neoplasm |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Synergism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Expression Regulation, Neoplastic |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HSP72 Heat-Shock Proteins |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Heat-Shock Proteins |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Myosin-Light-Chain Phosphatase |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neurofibromatosis 2 |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neurofibromin 2 |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phosphorylation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein Binding |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrrolidinones |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Signal Transduction |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Up-Regulation |
General subdivision | drug effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wu, Ji Yuan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Meng, Feng |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sun, Michael |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kopetz, Scott |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | McCutcheon, Ian E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Slopis, John M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kurzrock, Razelle |
773 0# - HOST ITEM ENTRY | |
Title | Molecular cancer therapeutics |
Related parts | vol. 10 |
-- | no. 11 |
-- | p. 2094-103 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1158/1535-7163.MCT-11-0243">https://doi.org/10.1158/1535-7163.MCT-11-0243</a> |
Public note | Available from publisher's website |
No items available.